| Bioactivity | PD-151307 is an N-type calcium channel antagonist with significant inhibitory effects in IMR-32 human neuroblastoma cells, exhibiting an IC50 of 0.32 µM. PD-151307 can be used in research related to cancer therapy, anticonvulsants, and neuropathic pain[1]. |
| CAS | 225925-12-2 |
| Formula | C33H47N3O5 |
| Molar Mass | 565.74 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Hu LY, et al. N,N-dialkyl-dipeptidylamines as novel N-type calcium channel blockers. Bioorg Med Chem Lett. 1999 Mar 22;9(6):907-12. |
PD-151307
CAS: 225925-12-2 F: C33H47N3O5 W: 565.74
PD-151307 is an N-type calcium channel antagonist with significant inhibitory effects in IMR-32 human neuroblastoma cell
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.